It is a pharma public limited company based in Pune, Maharashtra, India, established in 1981.
1981 | Pune, Maharashtra, India | ActiveLi Taka Pharmaceuticals Limited, a active public limited company, was established on 27 May 1981 in Pune, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24246MH1981PLC024490. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹4.00 Cr and a paid-up capital of ₹0.86 M.
Formerly known as Bora Pharmaceuticals Private Limited, Li Taka Chemicals Limited. It upholds a active non-compliant status. Its leadership includes Cajetan Valerian Dsouza (Director), Omprakash Pattanayak (Director), Pravinkumar Kantilal Mutha (Director). Past directors included Abhay Sadashiv Desai, Cajetan Valerian Dsouza, Swapnil Prakash Raka. It holds ₹1.06 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2013, with the balance sheet filed on 31 March 2013. It is based at Prema Chambers 156 B Ganesh Peth, Pune, Maharashtra, 411002.
U24246MH1981PLC024490
024490
27 May 1981
₹4.00 Cr
₹0.86 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Li Taka Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Cajetan Valerian Dsouza | Director | 01 Mar 2008 | Current |
| Omprakash Pattanayak | Director | 01 Oct 2011 | Current |
| Pravinkumar Kantilal Mutha | Director | 26 Mar 2009 | Current |
| Suresh Kanayalal Raka | Director | 26 Mar 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 26 Mar 2009 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2008 | Past |
| Pramod Abcsdd | Director | 01 Oct 2011 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2009 | Past |
| Pramod Abcsdd | Director | 01 Mar 2008 | Past |
| Pramod Abcsdd | Director | 01 Mar 2008 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Li Taka Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Li Taka Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹10,560,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Aug 2003 | Vishweshwar Sahakari Bank Ltd. | ₹4.00 M | Open |
| 23 Sep 1999 | Jana Seva Shahakari Bank Ltd. | ₹0.56 M | Open |
| 27 May 1999 | Jana Seva Shahakari Bank Ltd. | ₹2.00 M | Open |
| 02 Nov 1998 | Jana Seva Shahakari Bank Ltd. | ₹4.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Li Taka Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Li Taka Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Li Taka Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Li Taka Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2013 as per latest MCA records. was documented.
Progress on Li Taka Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2013 with Roc Pune. was documented.
Progress on Omprakash Pattanayak was appointed as a Director was appointed as a Director on 01 Oct 2011 & has been associated with this company since 14 years 2 months . was documented.
The activity Pravinkumar Kantilal Mutha was appointed as a Director was appointed as a Director on 26 Mar 2009 & has been associated with this company since 16 years 8 months . was completed.
The activity Suresh Kanayalal Raka was appointed as a Director was appointed as a Director on 26 Mar 2009 & has been associated with this company since 16 years 8 months . was completed.
The activity Cajetan Valerian Dsouza was appointed as a Director was appointed as a Director on 01 Mar 2008 & has been associated with this company since 17 years 9 months . was completed.
The CIN of Li Taka Pharmaceuticals Limited is U24246MH1981PLC024490.
Li Taka Pharmaceuticals Limited is headquartered at Prema Chambers 156 B Ganesh Peth, Pune, Maharashtra, 411002.
Li Taka Pharmaceuticals Limited was incorporated on 27 May 1981.
The current directors of Li Taka Pharmaceuticals Limited are
The primary industry of Li Taka Pharmaceuticals Limited is Pharma.
Li Taka Pharmaceuticals Limited is unlisted.
The authorized capital of Li Taka Pharmaceuticals Limited is ₹4.00 Cr, and the paid-up capital is ₹0.86 M.
The compliance status of Li Taka Pharmaceuticals Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX